nad+ glp 1 reviews Beware of TikTok GLP-1 Patches: Health Scam Alert NAD GLP
Description
Public reimbursement accounts for only 15% of the market, primarily covering patients with severe obesity and documented metabolic complications
(36464132) Antibody to insulin receptor (although this typically presents with extreme insulin resistance, causing diabetes)
10
The insurance route described above runs only through specialised endocrinology or obesity centres and is a separate path
Alternatively, switching to a different GLP-1 medication may be considered if side effects are intolerable, as individual responses vary between agents
No app or tool can predict a specific outcome
